Sarepta Therapeutics Depreciation & Amortization 2011-2026 | SRPT

Annual Depreciation & Amortization Sarepta Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
44.5 M	37.7 M	44.4 M	41.9 M	38 M	26.9 M	24.5 M	12.2 M	8.09 M	5.61 M	5.25 M	3.69 M	1.28 M	1.52 M	1.3 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
44.5 M	1.28 M	19.8 M

Quarterly Depreciation & Amortization Sarepta Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
677 K	667 K	9.98 M	-	602 K	601 K	8.74 M	-	439 K	179 K	11.3 M	-	178 K	179 K	10.7 M	-	27.9 M	179 K	8.93 M	165 K	19.6 M	13 M	6.53 M	200 K	17.9 M	11.1 M	4.88 M	216 K	8.72 M	5.12 M	2.25 M	216 K	5.97 M	3.41 M	1.64 M	29 K	3.95 M	2.87 M	1.4 M	-	3.88 M	2.57 M	1.28 M	-	2.53 M	1.48 M	523 K	-	998 K	711 K	451 K	-	1.09 M	715 K	353 K	-	763 K	490 K	239 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
27.9 M	29 K	4.17 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Amphastar Pharmaceuticals AMPH	31.6 M	$ 21.91	2.34 %	$ 1.02 B	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Aptorum Group Limited APM	1.13 M	$ 0.94	5.23 %	$ 6.91 M	China
ACADIA Pharmaceuticals ACAD	920 K	$ 22.7	3.37 %	$ 3.76 B	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	199 K	-	-2.5 %	$ 5.88 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	487 K	-	17.91 %	$ 11.1 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	548 K	$ 4.16	1.84 %	$ 445 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 23.75	2.09 %	$ 3.02 B	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	8.3 M	$ 1.45	0.35 %	$ 386 M	Britain
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.03	4.12 %	$ 4.99 M	Israel
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
bluebird bio BLUE	28 M	-	-	$ 546 M	USA
ContraFect Corporation CFRX	154 K	-	-5.16 %	$ 5.39 M	USA
Cardiff Oncology CRDF	364 K	$ 1.76	2.03 %	$ 118 M	USA
BioXcel Therapeutics BTAI	300 K	$ 1.11	4.25 %	$ 13.6 M	USA
Cabaletta Bio CABA	1.65 M	$ 3.02	2.43 %	$ 303 M	USA
Cara Therapeutics CARA	95 K	-	-3.03 %	$ 260 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
CASI Pharmaceuticals CASI	468 K	-	-	$ 35.4 M	USA
CymaBay Therapeutics CBAY	681 K	-	-	$ 3.45 B	USA